AxoGen (AXGN)
(Delayed Data from NSDQ)
$16.73 USD
+0.36 (2.20%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $16.74 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AXGN 16.73 +0.36(2.20%)
Will AXGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AXGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXGN
Are Medical Stocks Lagging AxoGen (AXGN) This Year?
Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?
AXGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates
Other News for AXGN
NR7 appears for AXGN after 0.24% move
Is AXGN building bullish momentum? Jack-in-the-box Bullish shows up after dropping 2.32%
Is AXGN likely to continue higher? Reversal New Highs Setup shows up after climbing 4.54%
Is AXGN preparing for a move? Bollinger Band Squeeze shows up after sliding 2.13%
Stochastic Reached Overbought appears for AXGN after 2.37% move